Medicine and Dentistry
Spinal Cord Injury
100%
Cyclosporin A [4 N Methylisoleucine]
100%
Mitochondrial Permeability
62%
Cyclosporine
50%
Immunosuppressive Drug
37%
Pharmacokinetics
12%
Convalescence
12%
Acute Heart Infarction
12%
Reperfusion Injury
12%
Traumatic Brain Injury
12%
Clinical Observation
12%
Cytoprotective Agent
12%
Cell Death
12%
Clinical Trial
12%
Repeated Drug Dose
12%
Therapeutic Window
12%
Cytotoxicity
12%
Neuroprotective Agent
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cyclosporin A [4 N Methylisoleucine]
100%
Spinal Cord Injury
100%
Ciclosporin
50%
Immunosuppressive Agent
37%
Acute Heart Infarction
12%
Reperfusion Injury
12%
Preclinical Study
12%
Experimental Rat
12%
Convalescence
12%
Clinical Trial
12%
Cytoprotective Agent
12%
Rat Model
12%
Therapeutic Window
12%
Neuroprotective Agent
12%
Traumatic Brain Injury
12%
Cytotoxicity
12%
Pharmacokinetics
12%
Neuroscience
Spinal Cord Injury
100%
Mitochondrial Permeability
62%
Ciclosporin
50%
Immunosuppressive Drug
37%
Mitochondrial Function
25%
Traumatic Brain Injury
12%
Pharmacokinetics
12%
In Vivo
12%
Cytotoxicity
12%
Cell Death
12%
Neuroprotective Agent
12%
Myocardial Infarction
12%
Neurotrauma
12%
Reperfusion Injury
12%